산소공급기 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

The future of the global oxygenator market looks promising with opportunities in the respiratory, cardiac, and extra-corporeal cardiopulmonary resuscitation markets. The global oxygenator market is expected to reach an estimated $482 million by 2035 with a CAGR of 5.3% from 2026 to 2035. The major drivers for this market are the increasing demand for heart-lung surgeries, the rising prevalence of respiratory disorders, and the growing adoption of advanced medical technologies.

• Lucintel forecasts that, within the type category, ECMO oxygenator is expected to witness higher growth over the forecast period.
• Within the application category, extra-corporeal cardiopulmonary resuscitation is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Oxygenator Market

The oxygenator market is experiencing rapid evolution driven by technological advancements, increasing demand for respiratory support, and a focus on improving patient outcomes. As healthcare systems worldwide adapt to new challenges, innovative solutions are emerging to enhance the efficiency, safety, and accessibility of oxygenation devices. These developments are not only transforming clinical practices but also expanding market opportunities across various regions. The following key trends highlight the dynamic nature of this market and its trajectory toward more advanced, patient-centric, and cost-effective oxygenation solutions.

• Technological Innovation: Advancements in membrane technology and miniaturization are leading to more efficient and portable oxygenators. These innovations improve oxygen transfer rates, reduce device size, and enhance ease of use, making them suitable for both ICU and transport settings. The integration of smart sensors and automation further optimizes performance and patient monitoring, ultimately improving clinical outcomes and reducing complications.
• Growing Adoption of ECMO: The increasing use of Extracorporeal Membrane Oxygenation (ECMO) systems, especially during respiratory crises like COVID-19, is expanding the market. ECMO provides life-saving support for severe respiratory failure, driving demand for high-performance oxygenators capable of handling complex procedures. This trend underscores the need for durable, biocompatible, and easy-to-maintain devices to meet critical care requirements.
• Rising Prevalence of Respiratory Diseases: The global increase in respiratory conditions such as COPD, ARDS, and pneumonia is fueling demand for oxygenators. Aging populations and environmental factors contribute to this rise, prompting healthcare providers to invest in advanced oxygenation devices. This trend is expected to sustain market growth and encourage innovation tailored to chronic and acute respiratory needs.
• Focus on Patient Safety and Biocompatibility: Manufacturers are prioritizing the development of oxygenators with enhanced biocompatibility to minimize adverse reactions and blood trauma. Innovations include surface coatings and materials that reduce clot formation and inflammatory responses. These improvements lead to safer, longer-lasting devices, which are crucial for both short-term interventions and long-term support, thereby increasing clinician confidence and patient safety.
• Market Expansion in Emerging Economies: Increasing healthcare infrastructure and rising awareness are driving market growth in regions such as Asia-Pacific, Latin America, and the Middle East. Local manufacturers are entering the market, offering cost-effective solutions that meet regional needs. This expansion broadens access to advanced oxygenation therapies and stimulates competitive innovation, ultimately making life-saving devices more accessible worldwide.

In summary, these trends are collectively reshaping the oxygenator market by fostering innovation, expanding application scope, and improving safety standards. They are enabling healthcare providers to deliver more effective respiratory support, reducing mortality rates, and broadening market reach across diverse geographic regions. As these developments continue, the market is poised for sustained growth and technological breakthroughs that will benefit patients globally.

Recent Developments in the Oxygenator Market

The oxygenator market is experiencing rapid advancements driven by technological innovations, increasing demand in healthcare, and expanding applications across medical procedures. These developments are transforming patient care, improving device efficiency, and opening new market opportunities. Stakeholders are focusing on enhancing device safety, reducing costs, and integrating smart technologies to meet evolving healthcare needs. The following key developments highlight the current trajectory and future potential of the oxygenator industry.

• Technological Innovations in Oxygenator Design: The industry is witnessing significant advancements in oxygenator technology, including miniaturization, improved heat exchange, and enhanced biocompatibility. These innovations lead to more efficient oxygen transfer, reduced blood trauma, and lower complication rates. Such improvements enable better patient outcomes, especially in critical care and long-term therapies. The adoption of novel materials and design modifications is also facilitating easier device handling and maintenance, thus expanding their clinical applications and market reach.
• Growing Demand in Cardiac and Respiratory Care: Increasing prevalence of cardiovascular and respiratory diseases is driving demand for oxygenators in hospitals and clinics worldwide. The rise in surgeries, including heart transplants and ECMO procedures, necessitates reliable oxygenation devices. This demand is further fueled by aging populations and rising chronic conditions. As a result, manufacturers are expanding production capacities and developing specialized oxygenators to cater to diverse clinical needs, thereby boosting market growth and ensuring better patient management.
• Integration of Smart Technologies and Digital Monitoring: The incorporation of IoT and digital monitoring systems into oxygenators is revolutionizing patient care. These smart devices enable real-time data collection, remote monitoring, and predictive maintenance, reducing complications and improving treatment outcomes. Hospitals benefit from enhanced device management and reduced operational costs. This technological integration is also fostering personalized therapies and improving clinical decision-making, positioning smart oxygenators as a key growth driver in the evolving healthcare landscape.
• Regulatory Approvals and Market Expansion: Recent regulatory approvals for innovative oxygenator devices are facilitating market expansion across emerging economies. Governments and health authorities are streamlining approval processes to encourage the adoption of advanced technologies. This regulatory support, combined with increasing healthcare infrastructure investments, is enabling manufacturers to penetrate new markets. Consequently, the global oxygenator market is experiencing accelerated growth, with increased access to life-saving devices in regions previously limited by regulatory or economic barriers.
• Focus on Cost Reduction and Device Longevity: Manufacturers are prioritizing the development of cost-effective oxygenators with longer lifespan and reduced maintenance needs. Innovations such as reusable components and improved durability are lowering overall healthcare costs and making advanced oxygenation therapy more accessible. These efforts are also reducing device replacement frequency, minimizing patient risk, and enhancing operational efficiency in healthcare facilities. Cost reduction strategies are crucial for expanding market penetration, especially in resource-constrained settings.

These developments are significantly transforming the oxygenator market by enhancing device performance, expanding clinical applications, and improving patient outcomes. Technological innovations, smart integrations, and regulatory support are driving market growth and global accessibility. As these trends continue, the industry is poised for sustained expansion, offering new opportunities for manufacturers, healthcare providers, and patients alike. The overall impact is a more efficient, cost-effective, and innovative oxygenation landscape that meets the evolving demands of modern medicine.

Strategic Growth Opportunities in the Oxygenator Market

The oxygenator market is experiencing rapid growth driven by advancements in medical technology, increasing demand for life-support systems, and expanding applications in critical care and surgical procedures. The rising prevalence of respiratory diseases and cardiovascular conditions further fuels market expansion. Innovations in device design, improved patient outcomes, and regulatory approvals are creating new opportunities for manufacturers. Strategic investments and collaborations are expected to accelerate market penetration across various healthcare settings, making oxygenators a vital component in modern medical interventions.

• Increasing Demand for Cardiopulmonary Bypass Oxygenators in Cardiac Surgeries: The rising number of cardiac surgeries globally boosts demand for CPB oxygenators, which are essential for maintaining blood oxygenation during procedures. Technological improvements, such as miniaturization and enhanced biocompatibility, are making these devices more efficient and safer. Growing awareness among healthcare providers and expanding surgical infrastructure in emerging markets further contribute to this trend, ensuring sustained market growth.
• Growing Adoption of Portable and Compact Oxygenators for Critical Care: The need for mobility and flexibility in intensive care units (ICUs) drives the development of portable oxygenators. These devices facilitate bedside procedures, transport, and emergency interventions, improving patient outcomes. Advances in miniaturization, energy efficiency, and ease of use are making portable oxygenators more accessible. As healthcare facilities seek versatile solutions, the adoption of these compact devices is expected to rise significantly, expanding market opportunities.
• Expansion of Oxygenator Use in Neonatal and Pediatric Care: Neonatal and pediatric patients require specialized oxygenation devices due to their unique physiological needs. The development of low-volume, biocompatible oxygenators tailored for infants and children is opening new markets. Increasing birth rates, neonatal intensive care unit (NICU) admissions, and technological innovations are driving demand. Manufacturers focusing on pediatric-specific solutions are poised to capitalize on this growth segment, improving survival rates and quality of care.
• Integration of Advanced Technologies Like ECMO In Respiratory and Cardiac Support: Extracorporeal Membrane Oxygenation (ECMO) systems, which incorporate oxygenators, are increasingly used for severe respiratory and cardiac failure cases. Technological advancements such as improved oxygenator membranes, automation, and monitoring systems enhance performance and safety. Growing clinical applications, especially during pandemics and complex surgeries, are expanding ECMO adoption. This integration of advanced technology is expected to significantly propel the market forward.
• Rising Focus on Innovation and Regulatory Approvals to Enhance Device Efficacy: Continuous innovation in oxygenator design, materials, and functionality is critical for market growth. Regulatory approvals ensure safety and efficacy, fostering trust among healthcare providers. Investment in research and development, along with strategic collaborations, accelerates product launches. These efforts lead to improved device performance, reduced complications, and broader acceptance, ultimately expanding the market landscape and enabling manufacturers to meet evolving clinical demands.

In conclusion, these growth opportunities collectively are set to transform the oxygenator market by fostering technological innovation, expanding application areas, and improving patient outcomes, thereby ensuring sustained industry expansion and increased healthcare integration worldwide.

Oxygenator Market Driver and Challenges

The oxygenator market is influenced by a complex interplay of technological advancements, economic conditions, and regulatory frameworks. Innovations in medical device technology, increasing healthcare expenditure, and evolving safety standards are shaping the market landscape. Additionally, demographic shifts such as aging populations and rising prevalence of respiratory diseases further drive demand. However, the market also faces challenges, including high manufacturing costs, stringent regulatory approvals, and supply chain disruptions. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving environment effectively and capitalize on growth opportunities while addressing potential risks.

The factors responsible for driving the oxygenator market include:

• Technological Innovation: The continuous development of advanced oxygenator devices, such as miniaturized and more efficient models, enhances patient outcomes and broadens application scope. Innovations like integrated monitoring systems and biocompatible materials improve safety and performance, encouraging adoption in hospitals and specialized clinics. These technological improvements reduce complications and increase the longevity of devices, making them more appealing to healthcare providers. As research progresses, the market benefits from new product launches that meet the increasing demand for minimally invasive and efficient oxygenation solutions, thus fueling growth.
• Rising Prevalence of Respiratory and Cardiac Diseases: The increasing incidence of chronic respiratory conditions like COPD, ARDS, and heart diseases globally is a significant driver. As these conditions often require advanced life support, the demand for oxygenators in critical care settings surges. Aging populations are particularly vulnerable, leading to higher hospitalization rates and greater need for durable oxygenation devices. This demographic trend, coupled with improved diagnostic capabilities, results in earlier detection and treatment, further expanding the market. The growing burden of these diseases underscores the importance of oxygenators in modern healthcare, supporting sustained market growth.
• Increasing Healthcare Expenditure: Governments and private sectors worldwide are investing more in healthcare infrastructure and advanced medical devices. Higher budgets enable hospitals to acquire state-of-the-art oxygenators, especially in developed regions. This financial support facilitates research, development, and procurement of innovative devices, ensuring better patient care. Additionally, insurance coverage and reimbursement policies in many countries make advanced oxygenation therapies more accessible, encouraging their widespread use. As healthcare spending continues to rise, the market for oxygenators is expected to expand, driven by the need for improved critical care solutions.
• Regulatory Approvals and Standards: Stringent regulatory frameworks ensure the safety and efficacy of oxygenator devices, fostering trust among healthcare providers and patients. Approval from agencies like the FDA and EMA accelerates market entry for new products and encourages innovation. Compliance with quality standards also reduces risks associated with device failure, which is crucial in life-support applications. Regulatory bodies evolving guidelines often push manufacturers to improve device performance and safety features, indirectly boosting market growth. While these regulations may pose initial hurdles, they ultimately contribute to a more reliable and competitive market environment.
• Strategic Collaborations and Mergers: Partnerships between device manufacturers, research institutions, and healthcare providers facilitate technological advancements and market expansion. Collaborations enable the sharing of expertise, resources, and distribution channels, accelerating product development and commercialization. Mergers and acquisitions also help companies strengthen their market position and diversify product portfolios. These strategic moves often lead to the introduction of innovative, cost-effective oxygenators, expanding access and adoption. Such collaborations are vital for navigating competitive landscapes and addressing unmet clinical needs, thereby propelling market growth.

The challenges in the oxygenator market are:

• High Manufacturing and Maintenance Costs: Developing advanced oxygenator devices involves significant investment in research, high-quality materials, and sophisticated manufacturing processes. These costs translate into higher prices for end-users, limiting accessibility, especially in low-resource settings. Additionally, ongoing maintenance and replacement parts contribute to the total cost of ownership, posing financial challenges for healthcare providers. The high costs can hinder widespread adoption and restrict market growth in emerging economies. Manufacturers must balance innovation with affordability to expand their customer base and ensure sustainable growth.
• Stringent Regulatory Approval Processes: The approval process for medical devices like oxygenators is complex, time-consuming, and costly. Navigating diverse regulatory requirements across different regions can delay product launches and increase development expenses. Failure to meet safety and efficacy standards can result in market rejections or recalls, damaging brand reputation. These regulatory hurdles can discourage innovation and limit the entry of new players, impacting market competitiveness. Companies must invest heavily in clinical trials and compliance activities, which can slow down market expansion and increase overall costs.
• Supply Chain Disruptions: The global supply chain for critical components and raw materials used in oxygenator manufacturing is vulnerable to disruptions caused by geopolitical tensions, pandemics, and logistical challenges. Such interruptions can lead to delays in production and delivery, affecting hospital procurement schedules and patient care. Shortages of specialized materials or components can also increase costs and reduce product availability. Ensuring a resilient supply chain is essential for maintaining market stability, but current vulnerabilities pose significant risks to consistent supply and market growth.

In summary, the oxygenator market is driven by technological innovations, rising disease prevalence, increased healthcare spending, regulatory support, and strategic collaborations. However, high costs, regulatory complexities, and supply chain issues present notable challenges. These factors collectively influence market dynamics, requiring stakeholders to innovate efficiently, navigate regulatory landscapes, and build resilient supply chains. Overall, while growth prospects remain promising, addressing these challenges is crucial for sustainable development and wider adoption of oxygenation technologies across diverse healthcare settings.

List of Oxygenator Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oxygenator companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oxygenator companies profiled in this report include-

• Medtronic
• Terumo
• Sorin Group
• EUROSETS S.r.l.
• Chalice Medical Ltd.
• Medos
• Maquet
• Nipro Medical
• Kewei
• WEGO

Oxygenator Market by Segment

The study includes a forecast for the global oxygenator market by type, application, and region.

Oxygenator Market by Type [Value from 2019 to 2035]:

• General Oxygenator
• ECMO Oxygenator

Oxygenator Market by Application [Value from 2019 to 2035]:

• Respiratory
• Cardiac
• Extra-Corporeal Cardiopulmonary Resuscitation
• Others

Oxygenator Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Oxygenator Market

The oxygenator market has experienced significant advancements driven by technological innovations, increasing healthcare demands, and the ongoing need for improved respiratory support systems worldwide. The COVID-19 pandemic accelerated the adoption of advanced oxygenation devices, prompting manufacturers to innovate and expand their product portfolios. Regulatory approvals and rising investments in healthcare infrastructure further influence market dynamics across different regions. Countries are focusing on developing more efficient, portable, and cost-effective oxygenators to meet diverse clinical needs. These developments reflect a global trend toward enhanced patient outcomes and technological integration in respiratory care.

• United States: The US market has seen rapid adoption of next-generation oxygenators with improved biocompatibility and efficiency. Major players are investing in research to develop portable and miniaturized devices suitable for emergency and ICU use. Regulatory agencies have approved several innovative products, boosting market growth. The increasing prevalence of respiratory diseases and COVID-19 cases has further driven demand. Hospitals are upgrading their respiratory support systems, emphasizing patient safety and comfort. Additionally, collaborations between biotech firms and healthcare providers are fostering innovation in oxygenator technology.
• China: China's oxygenator market is expanding due to rising healthcare infrastructure and government initiatives to improve critical care facilities. Domestic manufacturers are gaining prominence by offering cost-effective and technologically advanced products. The country's focus on reducing dependence on imports has led to increased R&D investments. The COVID-19 pandemic highlighted the need for efficient respiratory support, accelerating market growth. Urbanization and a growing aging population also contribute to increased demand for advanced oxygenation devices. Regulatory reforms are facilitating faster approval processes, encouraging local innovation and market entry.
• Germany: Germany's market is characterized by high-quality, technologically sophisticated oxygenators primarily used in advanced cardiac and respiratory surgeries. The country's strong healthcare system and emphasis on research and development support continuous innovation. German companies are focusing on developing oxygenators with enhanced biocompatibility and durability. The integration of digital monitoring systems is a recent trend, improving patient management. The COVID-19 pandemic underscored the importance of reliable respiratory support, prompting increased investment in oxygenator technology. Regulatory standards in Germany are stringent, ensuring high safety and efficacy levels for new products.
• India: The Indian oxygenator market is witnessing rapid growth driven by increasing healthcare expenditure and expanding critical care infrastructure. Local manufacturers are developing affordable, efficient oxygenators to cater to a large population with diverse healthcare needs. The government's focus on improving healthcare access and the rising burden of respiratory diseases are key factors. The COVID-19 crisis significantly boosted demand for oxygenation devices, prompting market players to innovate. Additionally, collaborations with international firms are facilitating technology transfer and product development. The market is expected to continue growing as healthcare facilities modernize and expand across urban and rural areas.
• Japan: Japan's market is characterized by advanced technological development and a focus on minimally invasive and portable oxygenators. The country's aging population has increased demand for respiratory support devices, especially in long-term care settings. Japanese companies are investing in R&D to improve device efficiency, biocompatibility, and integration with digital health systems. The COVID-19 pandemic accelerated the adoption of innovative oxygenators with enhanced safety features. Regulatory frameworks in Japan support high standards for medical devices, fostering innovation. The market is also influenced by collaborations between academia and industry to develop next-generation oxygenation solutions tailored to clinical needs.

Features of the Global Oxygenator Market

• Market Size Estimates: Oxygenator market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: Oxygenator market size by type, application, and region in terms of value ($M).
• Regional Analysis: Oxygenator market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the oxygenator market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oxygenator market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the oxygenator market by type (general oxygenator and ECMO oxygenator), application (respiratory, cardiac, extra-corporeal cardiopulmonary resuscitation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Oxygenator Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 General Oxygenator : Trends and Forecast (2019-2035)
• 4.4 ECMO Oxygenator : Trends and Forecast (2019-2035)

5. Global Oxygenator Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Respiratory : Trends and Forecast (2019-2035)
• 5.4 Cardiac : Trends and Forecast (2019-2035)
• 5.5 Extra-Corporeal Cardiopulmonary Resuscitation : Trends and Forecast (2019-2035)
• 5.6 Others : Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Oxygenator Market by Region

7. North American Oxygenator Market

• 7.1 Overview
• 7.2 North American Oxygenator Market by Type
• 7.3 North American Oxygenator Market by Application
• 7.4 The United States Oxygenator Market
• 7.5 Canadian Oxygenator Market
• 7.6 Mexican Oxygenator Market

8. European Oxygenator Market

• 8.1 Overview
• 8.2 European Oxygenator Market by Type
• 8.3 European Oxygenator Market by Application
• 8.4 German Oxygenator Market
• 8.5 French Oxygenator Market
• 8.6 Italian Oxygenator Market
• 8.7 Spanish Oxygenator Market
• 8.8 The United Kingdom Oxygenator Market

9. APAC Oxygenator Market

• 9.1 Overview
• 9.2 APAC Oxygenator Market by Type
• 9.3 APAC Oxygenator Market by Application
• 9.4 Chinese Oxygenator Market
• 9.5 Indian Oxygenator Market
• 9.6 Japanese Oxygenator Market
• 9.7 South Korean Oxygenator Market
• 9.8 Indonesian Oxygenator Market

10. ROW Oxygenator Market

• 10.1 Overview
• 10.2 ROW Oxygenator Market by Type
• 10.3 ROW Oxygenator Market by Application
• 10.4 Middle Eastern Oxygenator Market
• 10.5 South American Oxygenator Market
• 10.6 African Oxygenator Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global Oxygenator Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Medtronic
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Terumo
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Sorin Group
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 EUROSETS S.r.l.
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Chalice Medical Ltd.
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Medos
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Maquet
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Nipro Medical
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Kewei
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 WEGO
  • Company Overview
  • Oxygenator Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us